文献速递显微修复重建创面修复

脂肪干细胞联合血管化淋巴结移植治疗小鼠继发性淋巴水肿

Adipose-Derived Stem Cells and Vascularized Lymph Node Transfers Successfully Treat Mouse Hindlimb Secondary Lymphedema by Early Reconnection of the Lymphatic System and Lymphangiogenesis.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

该研究在小鼠后肢继发性淋巴水肿模型中,评估脂肪干细胞与血管化淋巴结移植联合治疗的效果。联合治疗组在吲哚菁绿荧光成像中显示立即染色和近端线性成像,水肿改善率和恶化率均显著优于其他治疗(p < 0.05),脂肪干细胞治疗组LYVE-1阳性淋巴管数量显著增加(p < 0.05)。结论认为联合治疗可能通过淋巴管生成和淋巴-静脉循环途径有效减轻水肿并恢复淋巴功能。

要点

  • 脂肪干细胞增加淋巴管数量,血管化淋巴结移植引导淋巴流向循环系统。
  • 联合治疗的水肿改善率和恶化率显著优于其他治疗(p < 0.05)。
  • 血管化淋巴结移植组在第28天出现B16黑色素瘤细胞转移。

核心结论

  • 脂肪干细胞联合血管化淋巴结移植可能通过淋巴管生成和淋巴-静脉循环途径有效减轻继发性淋巴水肿并恢复淋巴功能。

研究设计与样本

  • 10周龄雄性C57BL/6J小鼠,经30-Gy X线照射、手术淋巴结清扫和5-mm间隙创建后分为四组,接受血管化淋巴结转移腹部皮瓣和1.0×10脂肪干细胞治疗。

主要发现

  • 吲哚菁绿荧光Photodynamic Eye成像显示联合治疗组亚髂淋巴结立即染色并近端区域线性成像。
  • 联合治疗组的百分比改善和百分比恶化均显著优于其他治疗(p < 0.05)。
  • 脂肪干细胞治疗组LYVE-1免疫反应性淋巴管数量显著增加(p < 0.05)。
  • 血管化淋巴结移植治疗组至第28天出现B16黑色素瘤细胞转移。

临床怎么用

  • 联合脂肪干细胞与血管化淋巴结移植可能作为继发性淋巴水肿的潜在重建策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Secondary lymphedema is often observed in postmalignancy treatment of the breast and the gynecologic organs, but effective therapies have not been established in chronic cases even with advanced physiologic operations. Currently, reconstructive surgery with novel approaches has been attempted. METHODS: The hindlimbs of 10-week-old male C57BL/6J mice, after 30-Gy x-irradiation, surgical lymph node dissection, and 5-mm gap creation, were divided into four groups, with vascularized lymph node transfer abdominal flap and 1.0 × 10 adipose-derived stem cells. Lymphatic flow assessment, a water-displacement plethysmometer paw volumetry test, tissue quantification of lymphatic vessels, and functional analysis of lymphatic vessels and nodes were performed. RESULTS: Photodynamic Eye images, using indocyanine green fluorescence, demonstrated immediate staining in subiliac lymph nodes, and linear pattern imaging of the proximal region was observed with the combined treatment of adipose-derived stem cells and vascularized lymph node transfer. Both percentage improvement and percentage deterioration with the combined treatment of adipose-derived stem cells and vascularized lymph node transfer were significantly better than with other treatments (p < 0.05). The numbers of lymphatic vessels with LYVE-1 immunoreactivity significantly increased in mice treated with adipose-derived stem cells (p < 0.05), and B16 melanoma cells were metastasized in groups treated with vascularized lymph node transfers by day 28. CONCLUSIONS: Adipose-derived stem cells increase the number of lymphatic vessels and vascularized lymph node transfers induce the lymphatic flow drainage to the circulatory system. Combined adipose-derived stem cell and vascularized lymph node transfer treatment in secondary lymphedema may effectively decrease edema volume and restore lymphatic function by lymphangiogenesis and the lymphatic-to-venous circulation route.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hayashida K, Yoshida S, Yoshimoto H, et al. Adipose-Derived Stem Cells and Vascularized Lymph Node Transfers Successfully Treat Mouse Hindlimb Secondary Lymphedema by Early Reconnection of the Lymphatic System and Lymphangiogenesis. Plast Reconstr Surg. 2017. PMID: 28234840. doi:10.1097/PRS.0000000000003110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。